Hepatoprotective Effect Of Epigallocatechin-Gallate (Egcg) And Sorafenib Against Den Induced Hepato Cellular Carcinoma In Experimental Animals. Journal of Pharmaceutical Negative Results, [S. l.], p. 921–929, 2022. DOI: 10.47750/pnr.2022.13.S09.110. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/3403.. Acesso em: 6 jun. 2026.